Andrew was Chief Financial Officer and Head of Corporate Development at Terns Pharmaceuticals, and Chief Financial Officer at LeonaBio. Andrew Gengos joined Turn Therapeutics in 2026.
Andrew Gengos is currently
Create your alert
to follow the career of Andrew Gengos.
Andrew Gengos has a Bachelor of Science in Chemical Engineering from Massachusetts Institute of Technology in 1986 and a Master of Business Administration in Finance and Strategy from University of California, Los Angeles - Anderson School of Management in 1991.
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
They have also studied at University of California, Los Angeles - Anderson School of Management :
Find more alumni from University of California, Los Angeles - Anderson School of Management
Do you need to know more about Andrew Gengos? More results.
Report an error
Update the org chart details of Andrew Gengos.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.